{"id":551281,"date":"2026-09-21T15:45:29","date_gmt":"2026-09-21T15:45:29","guid":{"rendered":"https:\/\/www.newjerseyheadlines.com\/news\/story\/551281\/fetal-bovine-serum-market-size-to-reach-usd-175-billion-by-2031-driven-by-biopharma-scaleup-cell-therapy-pipelines-and-specialized-serum-grades.html"},"modified":"2026-09-21T15:45:29","modified_gmt":"2026-09-21T15:45:29","slug":"fetal-bovine-serum-market-size-to-reach-usd-175-billion-by-2031-driven-by-biopharma-scaleup-cell-therapy-pipelines-and-specialized-serum-grades","status":"publish","type":"post","link":"http:\/\/www.northcarolinaheadlines.com\/news\/story\/551281\/fetal-bovine-serum-market-size-to-reach-usd-175-billion-by-2031-driven-by-biopharma-scaleup-cell-therapy-pipelines-and-specialized-serum-grades.html","title":{"rendered":"Fetal Bovine Serum Market Size to Reach USD 1.75 Billion by 2031, Driven by Biopharma Scale-Up, Cell Therapy Pipelines, and Specialized Serum Grades"},"content":{"rendered":"
\"Fetal<\/a><\/div>\n
Mordor Intelligence has published a new report on the Fetal Bovine Serum Market, offering a comprehensive analysis of market trends, growth drivers, segmentation, competitive landscape, and future projections.<\/div>\n

Hyderabad, India – 21 September 2026, According to Mordor Intelligence, the Fetal Bovine Serum Market size is projected to increase from USD 1.30 billion in 2026 to USD 1.75 billion by 2031, registering a CAGR of 6.20% during the forecast period. North America currently represents the largest regional market, while Asia Pacific is expected to record the fastest growth. Rising biopharmaceutical production, expanding cell and gene therapy pipelines, vaccine manufacturing, and increasing contract cell-culture activity are supporting demand for fetal bovine serum (FBS).<\/p>\n

Fetal bovine serum is widely used as a cell-culture supplement across research, testing, and biomanufacturing workflows. Its continued use in validated cell culture processes supports demand across biotechnology and pharmaceutical companies, academic research, contract manufacturing organizations, vaccine producers, and other life-science applications. At the same time, stricter traceability requirements, ethical concerns, price volatility, and growing adoption of serum-free media are influencing the direction of the Fetal Bovine Serum industry.<\/p>\n

Report Overview: https:\/\/www.mordorintelligence.com\/industry-reports\/fetal-bovine-serum-market?utm_source=abnewswire<\/a><\/p>\n

 <\/p>\n

Fetal Bovine Serum Market Trends<\/p>\n

Expanding Biopharmaceutical Production<\/p>\n

Biopharmaceutical manufacturing remains an important source of demand for FBS because established cell culture and seed-train processes continue to use serum-supplemented media. Contract manufacturers also procure serum according to customer-specific grades and lot-testing requirements, creating recurring demand across development and production activities.<\/p>\n

The expansion of biologics manufacturing capacity is therefore supporting the Fetal Bovine Serum Market growth, even as newer facilities increasingly evaluate serum-free alternatives. Existing validated processes can require extensive comparability work before changing media systems, helping sustain FBS consumption in established manufacturing workflows.<\/p>\n

Growth in Cell and Gene Therapy Research<\/p>\n

Cell and gene therapy development is another important factor influencing Fetal Bovine Serum Market trends. Advanced therapies frequently involve ex vivo cell expansion, where qualified serum grades may be selected according to process requirements. Demand for stem-cell-qualified FBS is particularly supported by regenerative medicine and specialized research applications.<\/p>\n

The need for consistent serum quality, lot qualification, and contaminant testing also favors specialized products. These requirements can make premium grades more attractive for research and clinical development programs where changing an established serum source may introduce additional validation requirements.<\/p>\n

Increasing Vaccine Manufacturing Demand<\/p>\n

Human and animal vaccine manufacturing continues to support FBS consumption. Primary cell lines and other culture systems used during vaccine development and production can depend on serum, particularly where established manufacturing processes remain in place. Vaccine activity across Asia Pacific and South America is contributing to demand for appropriate serum grades.<\/p>\n

Contract manufacturing is also creating additional purchasing requirements because manufacturers must accommodate different client specifications. This supports the Fetal Bovine Serum Market forecast even as some newer production processes transition toward chemically defined media.<\/p>\n

Growing Adoption of Specialized FBS Grades<\/p>\n

Product differentiation is becoming increasingly important within the market. Charcoal\/dextran-stripped FBS accounted for 31.55% of market revenue in 2025, while stem-cell-qualified FBS is forecast to grow faster than the overall market. Heat-inactivated, dialyzed, exosome-depleted, gamma-irradiated, and low-IgG grades serve more specific research and biomanufacturing requirements.<\/p>\n

Specialized grades can command higher value because researchers and manufacturers require greater consistency, traceability, and suitability for specific applications. This is creating a market divide between standard serum products and higher-specification grades designed for performance-sensitive workflows.<\/p>\n

Fetal Bovine Serum Market Segmentation<\/p>\n

By Product Type<\/p>\n